Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98), b) 14-count bot...
FDA Drug Recall #D-0441-2017 — Class II — December 20, 2016
Recall Summary
| Recall Number | D-0441-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 20, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mylan LLC. |
| Location | Caguas, PR |
| Product Type | Drugs |
| Quantity | a) 574 bottles (lot 2006895) and 495 bottles (lot 2006896); b) 744 bottles (lot 2006895) |
Product Description
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98), b) 14-count bottles (NDC 0378-5262-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.
Reason for Recall
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Distribution Pattern
Nationwide in the USA
Lot / Code Information
LOT #: a) 2006895 and 2006896, Exp 02/18; b) 2006895, Exp 02/18
Other Recalls from Mylan LLC.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0444-2017 | Class II | Temozolomide Capsules, 250 mg, 5-count bottles,... | Dec 20, 2016 |
| D-0443-2017 | Class II | Temozolomide Capsules, 180 mg, packaged in a) 5... | Dec 20, 2016 |
| D-0442-2017 | Class II | Temozolomide Capsules, 140 mg, packaged in a) 5... | Dec 20, 2016 |
| D-066-2013 | Class II | Mylan, Tacrolimus Capsules 0.5 mg, 100 count bo... | Jun 29, 2012 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.